Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
CD26 is a lymphocyte cell surface antigen which is increased during T-cell activation and is also expressed in other tissues. It is an atypical serine protease belonging to the prolyl oligopeptidase family. CD26 has been implicated in a variety of biological functions including T-cell activation, cell-to-cell adhesion, and recently in HIV infection. This paper describes, through the isolation and partial sequencing of eight human CD26 genomic clones, the first information on the genomic organization of the prolyl oligopeptidase family. We have established that the human CD26 gene spans approximately 70 kilobases (kb) and contains 26 exons, ranging in size from 45 base pairs (bp) to 1.4 kb. The nucleotides that encode the serine recognition site (G-W-S-Y-G) are split between two exons. This clearly distinguishes the genomic organization of the prolyl oligopeptidase family from that of the classical serine protease family. The 5' flanking domain of the CD26 gene contains neither a TATA box nor a CAAT box, but a 300 bp region extremely rich in C and G (72%) contains potential binding sites for several transcriptional factors. The human CD26 gene encodes two messages sized at about 4.2 and 2.8 kb. These are both expressed at high levels in the placenta and kidney and at moderate levels in the lung and liver. Only the 4.2 kb mRNA was expressed at low levels in skeletal muscle, heart, brain, and pancreas. Fluorescence in situ hybridization on metaphase chromosome spreads located th…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The regulation of DPPIV expression seems to be tissue specific, 28,29 and soluble antigen concentrations may reflect not only expression but also cleavage from the cell surface.”
From Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema (2008) · cites this paper as [28]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90611-8 · Cited by 2,931 · cited 1×
“AP-1 and AP-2 sites have been identif ied in genes whose transcription is induced by phorbol esters, including cellular proto-oncogenes such as c- fos and c - m y c (Angel et al. 1987; Lee et al. 1987).”
Lee, W., Haslinger, A., Karin, M., & Tjian, R. (1987) · Nature · doi:10.1038/325368a0 · Cited by 731 · cited 1×
“AP-1 and AP-2 sites have been identif ied in genes whose transcription is induced by phorbol esters, including cellular proto-oncogenes such as c- fos and c - m y c (Angel et al. 1987; Lee et al. 1987).”
Proline-Dependent Structural and Biological Properties of Peptides and Proteins
Yaron, A., Naider, F., & Scharpe, S. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309082572 · Cited by 551
Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., & Morimoto, C. (1993) · Science · doi:10.1126/science.8101391 · Cited by 507 · cited 1×
“Furthermore, CD26 has been shown to bind adenosine deaminase ADA; (Morrison et al. 1993; Kameoka et al. 1993).”
SIGNAL SCAN: a computer program that scans DNA sequences for eukaryotic transcriptional elements
Prestridge, D. S. (1991) · Bioinformatics · doi:10.1093/bioinformatics/7.2.203 · Cited by 489
Ishii, S., Xu, Y. H., Stratton, R. H., Roe, B. A., Merlino, G. T., & Pastan, I. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4920 · Cited by 373
CD26: a surface protease involved in T-cell activation
Fleischer, B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90316-6 · Cited by 325 · cited 2×
“The full spectrum of CD26 function remains unclear (Fleischer 1994).”
Human N-myc is closely related in organization and nucleotide sequence to c-myc
Kohl, N. E., Legouy, E., DePinho, R. A., Nisen, P. D., Smith, R. K., Gee, C. E., & Alt, F. W. (1986) · Nature · doi:10.1038/319073a0 · Cited by 274 · cited 1×
“Promoters of this type are known to regulate the expression of proto-oncogenes such as Pim 1, N-myc, or H-ras (Ishii et al. 1985 a; Kohl et al. 1986; Meeker et al. 1990) and growth factor receptors such as epidermal growth factor receptor (Ishii et al.”
Cited by
Items 101–179 of 179
Kim, S., & Cho, E.-H. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.1.93 · Cited by 19
Turcot, V., Tchernof, A., Deshaies, Y., Përusse, L., Bélisle, A., Marceau, P., Hould, F., Lebel, S., & Vohl, M. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-4 · Cited by 20
“stimulated T-cells, Bcells and natural killer cells) [5-7].”
BackgroundCOVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies
Yang, Y., Zhao, Y., Zhang, F., Zhang, L., & Li, L. (2020) · Aging and Disease · doi:10.14336/ad.2020.0903 · Cited by 22
“liver, gut, and immune cell s(including T-cells, activated B-cells, activated natural killer cells and myeloid cells) [52, 53].”
BackgroundArndt, M., Lendeckel, U., Spiess, A., Faust, J., Neubert, K., Reinhold, D., & Ansorge, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3144 · Cited by 18
Misumi, Y., & Ikehara, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00745-6 · Cited by 20
Immunomodulatory activity of dipeptidyl peptidase‐4 inhibitors in immune‐related diseases
Drakul, M., & Čolić, M. J. (2023) · European Journal of Immunology · doi:10.1002/eji.202250302 · Cited by 19
“3, spans 81.8 kb, and contains 26 exons [5].”
BackgroundInfluentialJang, J., Yamada, Y., Janker, F., Meester, I. D., Baerts, L., Vliegen, G., İnci, İ., Chatterjee, S., Weder, W., & Jungraithmayr, W. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.10.080 · Cited by 17
Dipeptidyl peptidase IV(DPP IV): a novel emerging target for the treatment of type 2 diabetes
Wu, J. Q., Chen, Y., Shi, X., & Gu, W. (2009) · 南京医科大学学报:英文版 · doi:10.1016/s1007-4376(09)60061-7 · Cited by 17
“The enzyme is widely distributed in numerous tissues such as kidney, intestine, liver, spleen, placenta, adrenal glands, lymphocytes, and endothelial cells[21].”
BackgroundNagatsu, T. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1604-8 · Cited by 15
“, being found in kidney, small intestine, placenta, submaxillary gland, lung, spleen, liver, pancreas, heart, and brain (Abbott et al. 1994).”
BackgroundEnzymatic activity of DPIVCD26 is involved in PMA-induced hyperphosphorylation of p56lck
Kähne, T., Neubert, K., & Ansorge, S. (1995) · Immunology Letters · doi:10.1016/0165-2478(95)00041-3 · Cited by 15
Ukwenya, V. O., Adelakun, S. A., & Elekofehinti, O. O. (2021) · In Silico Pharmacology · doi:10.1007/s40203-021-00084-z · Cited by 14
Karandikar, S. S., Soni, R., Soman, S. S., Umar, S., & Balakrishnan, S. (2018) · Synthetic Communications · doi:10.1080/00397911.2018.1508723 · Cited by 13
Lian, W.-N., Wu, T., Dao, R., Chen, Y.-J., & Lin, C.-H. (2005) · Journal of Cell Science · doi:10.1242/jcs.02706 · Cited by 13
“On the other hand, dipeptidylpeptidase IV (DPPIV) was present predominantly on the apical domain (Abbott et al., 1994), making the bile canaliculi in the color-merged panel appear yellow (arrows).”
BackgroundHuman Thymocyte Dipeptidyl Peptidase IV (CD26) Activity Is Altered with Stage of Ontogeny
Ruiz, P., Zacharievich, N., Lei, H. C., Viciana, A. L., & Shenkin, M. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4550 · Cited by 13
Piao, L., Li, Y., Narisawa, M., Shen, X., & Cheng, X. W. (2021) · International Heart Journal · doi:10.1536/ihj.20-181 · Cited by 12
SCHUBERT, W. J., Friedenberger, M., Haars, R., Bode, M., Philipsen, L., Nattkemper, T. W., & Ritter, H. J. (2001) · Computational and Mathematical Methods in Medicine · doi:10.1080/10273660290015189 · Cited by 12
Bernstein, H., Keilhoff, G., Dobrowolny, H., & Steiner, J. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0026 · Cited by 11
Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance
Mietlicki‐Baase, E. G., McGrath, L. E., Koch‐Laskowski, K., Krawczyk, J., Pham, T., Lhamo, R., Reiner, D. J., & Hayes, M. R. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.01.038 · Cited by 11
Ruiz, P., Zacharievich, N., & Shenkin, M. (1998) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.3.362-368.1998 · Cited by 11
Ruiz, P., Hao, L., Zucker, K. E., Zacharievich, N., Viciana, A. L., Shenkin, M., & Miller, J. (1997) · Transplant Immunology · doi:10.1016/s0966-3274(97)80056-1 · Cited by 11
Thongtak, A., Yutisayanuwat, K., Harnkit, N., Noikaew, T., & Chumnanpuen, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115730 · Cited by 12
“DPPIV is expressed in cells such as intestinal epithelial cells [12], which accelerate the breakdown of incretin hormone groups including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).”
BackgroundHuman Coronavirus Cell Receptors Provide Challenging Therapeutic Targets
López-Cortés, G. I., Palacios-Pérez, M., Hernández-Aguilar, M. M., Veledíaz, H. F., & José, M. V. (2023) · Vaccines · doi:10.3390/vaccines11010174 · Cited by 10
“A range of leukocyte populations, including T, B, NK, and dendritic cells, express DPP-IV, as well as fibroblast, endothelial cells, epithelial cells of the kidney, liver, lung, small intestine, esophagus, breast, and prostate [48].”
BackgroundMatsui, M., Takahashi, Y., Takebe, N., Takahashi, K., Nagasawa, K., Honma, H., Oda, T., Ono, M., Nakagawa, R., Sasai, T., et al. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12260 · Cited by 13
Ruiz, P., Zacharievich, N., Viciana, A. L., & Shenkin, M. (1998) · Acta Haematologica · doi:10.1159/000040880 · Cited by 10
Corley, P. A. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90040-2 · Cited by 10
Chihara, C. J., Song, C., LaMonte, G., Fetalvero, K. M., Hinchman, K. F., Phan, H., Pineda, M. J., Robinson, K., & Schneider, G. P. (2005) · Journal of Insect Science · doi:10.1093/jis/5.1.26 · Cited by 10
Increased serum levels of dipeptidyl peptidase IV (CD26) in rats undergoing liver regeneration
Abbott, C. A., Gorrell, M. D., Kobayashi, Y., KAWASAKI, T., Liddle, C., Bishop, G. A., & McCaughan, G. W. (1995) · International Hepatology Communications · doi:10.1016/0928-4346(95)00242-1 · Cited by 10
Self-citationMolecular Analyses of Human and Rat Dipeptidyl Peptidase IV
Abbott, C. A., Gorrell, M. D., Levy, M. T., & McCaughan, G. W. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9613-1_21 · Cited by 10
Self-citationKraml, J., Kolinska, J., Šinkora, J., Zákostelecká, M., Kadlecová, L., Hirsová, D., & Nosková, L. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.07.002 · Cited by 9
Clot, F., Babron, M., Percopo, S., Giordano, M., Bouguerra, F., Clerget‐Darpoux, F., Greco, L., Serre, J., & Fulchignoni‐Lataud, M. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2000.tb02774.x · Cited by 9
Biftu, T., & SinhaRoy, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12443-6 · Cited by 14
Sarashina, A., Chiba, K., Tatami, S., & Kato, Y. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.03.031 · Cited by 9
Proteins Expressed by Pancreatic Duct Cellsand Their Relatives
Hollingsworth, M. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09508.x · Cited by 8
Puente, X. S., Pendás, A. M., & López-Otín, C. (1998) · Genomics · doi:10.1006/geno.1998.5351 · Cited by 8
Graft-versus-host disease: teaching old drugs new tricks at less cost
Farhan, S., & Holtan, S. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1225748 · Cited by 7
“In addition, the CD26/ DPP4 homodimer is expressed in many tissues like the lung and intestine and many other immune cells like B and T cells, activated NK cells, and myeloid cells (86, 87).”
BackgroundCD26+ Cord Blood Mononuclear Cells Significantly Produce B, T, and NK Cells.
Serej, Z. A., Alemi, F., Brazvan, B., Nasrabadi, H. T., & Charoudeh, H. N. (2015) · PubMed · doi:10.22034/iji.2015.16731 · Cited by 7
Mokoš, Z. B., Petković, M., Balić, A., & Marinović, B. (2020) · Croatian Medical Journal · doi:10.3325/cmj.2020.61.93 · Cited by 7
Li, Q., Qin, X., Kou, X., Li, J., Li, Z., & Chen, C. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11211 · Cited by 6
“Dipeptidyl‐peptidase‐4 (DPP‐4) is a ubiquitously expressed transmembrane exopeptidase found on the surface of numerous hematopoietic cells (12).”
BackgroundDipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review 2019 – present
Abbas, G., Akhtar, M. S., Haq, Q. M. I., Al-Amri, I. S., Wang, D., & Hussain, H. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2446226 · Cited by 7
“It is a homodimer enzyme with a catalytic triad of serine, histidine, and aspartate residues at its active site [6].”
Stubbe, H. C., Dahlke, C., Rotheneder, K., Stirner, R., Roider, J., Conca, R., Seybold, U., Bogner, J. R., Addo, M. M., & Draenert, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239399 · Cited by 6
“The gene DPP4 is located on long arm of chromosome 2 [26].”
BackgroundWagner, L., Hoffmann, T., Rahfeld, J., & Demuth, H. (2006) · Springer eBooks · doi:10.1007/0-387-32824-6_12 · Cited by 6
Gum, J. R., Erickson, R. H., Hicks, J. W., Rius, J. L., & Kim, Y. S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02013-5 · Cited by 6
Proteases in the Nervous System
Cynis, H., Lichtenthaler, S. F., Wagner, L., & Demuth, H. (2013) · Springer eBooks · doi:10.1007/978-3-7091-0885-7_10 · Cited by 4
Dipeptidyl Peptidase IV in Inflammatory Bowel Diseases (DPP IV/CD26)
Pučar, L., Detel, D., & Varljen, J. (2012) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/10004-1254-63-2012-2185 · Cited by 6
DPPIV/CD26 as a Target in Anti-inflammatory Therapy
Vliegen, G., & Meester, I. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805417-8.00011-1 · Cited by 6
Specific Inhibitors of Dipeptidyl Peptidase IV Suppress mRNA Expression of DP IV/CD26 and Cytokines
Arndt, M., Reinhold, D., Lendeckel, U., Spiess, A., Faust, J., Neubert, K., & Ansorge, S. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46826-3_15 · Cited by 4
CD26/DPPIV and response to hepatitis B vaccination
Dourado, M., Alves, V., Mesquita, L., Ramos, I. M., Mota‐Pinto, A., & Rosa, M. S. (2004) · Pathophysiology · doi:10.1016/j.pathophys.2004.06.002 · Cited by 3
Józefiak, A., Woźniak, M., & Jaśkowski, J. M. (2015) · Annals of Animal Science · doi:10.1515/aoas-2015-0043 · Cited by 3
Amirat, A., Almasalma, M., Elshazly, M. A., Elhosary, M. M., & Younes, M. (2026) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251413943 · Cited by 2
Dipeptidyl Peptidase Inhibitors: A New Step Towards Normoglycemia
Fredenrich, A., Palle, S., & Canivet, B. (2009) · The Open Endocrinology Journal · doi:10.2174/1874216500903010016 · Cited by 2
LORENZO, R. D., Monno, A., Sciorati, C., Lorenzetti, I., Cavalli, S., Bonomi, F., Previtali, S. C., & Rovere, P. Q. (2022) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/rdm3kg · Cited by 2
Bauvois, B., Nguyen‐Khac, F., Merle‐Béral, H., & Susín, S. A. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.006 · Cited by 3
Zia, A., Sahebdel, F., Farkhondeh, T., Pourbagher‐Shahri, A. M., Samini, F., & Samarghandian, S. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010328697250210065420 · Cited by 3
Martín, P. B. P., & de Pablos-Velasco, P. L. (2010) · Medicina Clínica · doi:10.1016/s0025-7753(10)70029-4 · Cited by 4
Role of Proteases in Diabetes Mellitus
Ghosh, S., Pandey, B., & Sil, P. C. (2017) · Springer eBooks · doi:10.1007/978-981-10-6141-7_20 · Cited by 1
SAFETY PROFILE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS
Ganeva, M. G. (2023) · Trakia Journal of Sciences · doi:10.15547/tjs.2023.01.009 · Cited by 2
del Bosque, A. Q. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
The study of a new and specific proline cleaving peptidase from bovine serum
Collins, P. (2003) · Dublin City University Open Access Institutional Repository (Dublin City University)
Kang, H. (2014) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v13i6.5
“DPP4 contains three major activity domains including α-hydrolase (AA:39-51), βpropeller domain (AA:55-497) and β-hydrolase domain (AA:506-766) [1].”
BackgroundDipeptidyl-Peptidase IV inhibitors and glycemic control in type 2 Diabetes Mellitus
Sapkota, L. B., & Thapa, S. (2016) · Journal of College of Medical Sciences-Nepal · doi:10.3126/jcmsn.v12i1.14684
C1‐Inhibitor to Choriogonadotropin
Haeberli, A. (1998) · Wiley eBooks · doi:10.1002/9783527619764.ch3
Dipeptidyl-peptidase IV inhibitors and glycemic control in type 2 diabetes mellitus
Sapkota, L. B., & Thapa, S. (2017) · Journal of Chitwan Medical College · doi:10.3126/jcmc.v6i1.16656
Wound healing process and dipeptidyl peptidase IV
Batičić, L., Grčić, A., Pugel, E. P., Detel, D., & Varljen, J. (2017) · Medicina · doi:10.21860/medflum2017_173375
(2021) · Wiley eBooks · doi:10.1002/9781119611288.refs
(1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80115-4
Fleischer, B. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm1003
Barclay, A. N., Brown, M. H., Law, S. K. A., McKnight, A. J., Tomlinson, M. G., & van der Merwe, P. A. (1997) · Elsevier eBooks · doi:10.1016/b978-012078185-0/50460-1
赵, 泽. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1381737
Nishida, H., Suzuki, R., Nakajima, K., Hayashi, M., Morimoto, C., & Yamada, T. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0215
Bozorgmehr, N., Hnatiuk, M., Peters, A., & Elahi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26564556
Bozorgmehr, N., Hnatiuk, M., Peters, A., & Elahi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26564553
Larraufie, P. (2015) · theses.fr (ABES) · doi:10.70675/ce2b5de8zb636z46dfz9748z89bdde5af84d
Hollande, C. (2017) · theses.fr (ABES) · doi:10.70675/744e49c0zbc92z486czbb30z3cc0f07dde53
Valverde, A. (2020) · theses.fr (ABES) · doi:10.70675/f1b70734zf4e3z4870z8fbdz950d831642a7
Regulatory and Safety Challenges in Nano-Targeted Nutraceutical Development
Borat, S., Sarkar, S., Srivstava, S., Sharma, S., Chakraborty, S., & Bisht, A. (2025) · doi:10.70593/978-93-7185-822-9_13
The role of DPP4 in viral infections: from receptor biology to antiviral target
Aguilera-Flores, C., & Arias, C. F. (2026) · Archives of Virology · doi:10.1007/s00705-026-06669-3
“Dipeptidyl Peptidase 4 (DPP4), also known as Cluster of Differentiation 26 (CD26), is a highly glycosylated type II transmembrane serine protease [1– 3 ].”
The Effect of DPP10 in Smoking and Vaping Induced Apoptosis and Inflammation
Afonja, A. (2026) · BCU Open Access Repository (Birmingham City University)
CD26/DPIV in Hematopoietic Cells — Expression, Function, Regulation, Clinical Aspects
Kähne, T., Wrenger, S., Manutscharow, A., & Reinhold, D. (2002) · Springer eBooks · doi:10.1007/978-1-4615-0619-5_8
Metadata
- Authors
- Abbott, C. A., McCaughan, G. W., Baker, E., & Sutherland, G. R.
- Affiliations
- Royal Prince Alfred Hospital (AU)
- Women's and Children's Hospital (AU)
- Venue
- Immunogenetics
- Published
- 1994-09
- Volume
- 40
- Issue
- 5
- Pages
- 331-338
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2027150840
- Cited by
- 177
- References
- 46
- Citations by year
- 2026: 2 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 6 · 2018: 2 · 2017: 10 · 2016: 8 · 2015: 8 · 2014: 8 · 2013: 3 · 2012: 5
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Immunogenetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- CD26, dipeptidyl peptidase IV, gene structure, exon-intron organization, serine protease, T cell activation, tissue expression, 5'-flanking region, transcriptional regulatory elements, gene mapping, HIV infection
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 2, Cloning, Molecular, Exons, Humans, Introns, Male, Molecular Sequence Data, Restriction Mapping, DNA Probes, Genome, Dipeptidyl Peptidase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.